• user warning: Table './fnndrupaldev/term_node' is marked as crashed and last (automatic?) repair failed query: SELECT t.* FROM term_node r INNER JOIN term_data t ON r.tid = t.tid INNER JOIN vocabulary v ON t.vid = v.vid WHERE r.vid = 437992 ORDER BY v.weight, t.weight, t.name in /var/www/www.fnno.com/htdocs/modules/taxonomy/taxonomy.module on line 617.
  • user warning: Table './fnndrupaldev/sessions' is marked as crashed and last (automatic?) repair failed query: SELECT COUNT(sid) AS count FROM sessions WHERE timestamp >= 1414166100 AND uid = 0 in /var/www/www.fnno.com/htdocs/includes/session.inc on line 111.
  • user warning: Table './fnndrupaldev/sessions' is marked as crashed and last (automatic?) repair failed query: SELECT DISTINCT u.uid, u.name, s.timestamp FROM users u INNER JOIN sessions s ON u.uid = s.uid WHERE s.timestamp >= 1414166100 AND s.uid > 0 ORDER BY s.timestamp DESC in /var/www/www.fnno.com/htdocs/modules/user/user.module on line 765.

Analyst Rating In Review: Endo Pharmaceuticals Bid Up 8.6% Since Downgraded 7 Days Ago (ENDP)

Published on Thu, 02/07/2013 - 10:09
By Robert Cotter

A week ago, Oppenheimer downgraded Endo Pharmaceuticals from Outperform to Perform. The stock closed at $30.66, which is 8.6% higher than the price one week ago ($28.23).

In the past 52 weeks, shares of Endo Pharmaceuticals have traded between a low of $25.00 and a high of $44.53 and are now at $30.40, which is 22% above that low price. Over the last five market days, the 200-day moving average (MA) has gone down 0.2% while the 50-day MA has advanced 0.7%.

There is potential upside of 9.6% for shares of Endo Pharmaceuticals based on a current price of $30.40 and an average consensus analyst price target of $33.31. The stock should find initial support at its 200-day moving average (MA) of $30.27 and further support at its 50-day MA of $27.56.

Endo Pharmaceuticals Holdings Inc. is a specialty pharmaceutical company with products that provide pain management. The Company researches, develops, produces, and markets both branded and generic pharmaceuticals. Endo's products include Percocet, Percodan, and Lidoderm.

By Robert Cotter
rcotter@fnno.com

Latest News from FNNO

Micron Technology is Among the Companies...

Below are the three companies in the Semiconductors industry with the highest earnings ...

Bearish Moving Average Cross by CARBO Ce...

CARBO Ceramics (NYSE:CRR) crossed under its 10-day moving average of $52.65 on a volume ...

Dynamic Materials Makes a Move: Down 1.8...

Dynamic Materials (NASDAQ:BOOM) is one of today's notable stocks in decline, down 1.8% ...

Iridiummmunications is Among the Compani...

Below are the three companies in the Alternative Carriers industry with the highest ear ...

Medicines Co Bearish Moving Average Cros...

Today, shares of Medicines Co (NASDAQ:MDCO) have crossed bearishly below their 10-day m ...

E-House China Makes a Move: Down 1.8%...

Down 1.8% to $9.78, E-House China (NYSE:EJ), is one of today's notable movers. The S&P ...

Public Service Enterprise Group has the ...

Below are the three companies in the Multi-Utilities industry with the highest earnings ...

Bullish Moving Average Cross by RealPage...

RealPage (NASDAQ:RP) crossed over its 10-day moving average of $16.45 on a volume of 46 ...